Results 141 to 150 of about 5,768 (162)

Who truly benefits from gilteritinib combinations in FLT3-mutated relapsed-refractory(R/R) AML: a Canadian single center analysis. [PDF]

open access: yesBlood Cancer J
Rajendra A   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy